325 related articles for article (PubMed ID: 24882784)
1. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
Rosenkrantz AB; Wehrli NE; Melamed J; Taneja SS; Shaikh MB
Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.
Jhaveri KS; Elmi A; Hosseini-Nik H; Hedgire S; Evans A; Jewett M; Harisinghani M
AJR Am J Roentgenol; 2015 Jul; 205(1):W79-86. PubMed ID: 26102422
[TBL] [Abstract][Full Text] [Related]
3. In-phase signal intensity loss in solid renal masses on dual-echo gradient-echo MRI: association with malignancy and pathologic classification.
Childs DD; Clingan MJ; Zagoria RJ; Sirintrapun J; Tangtiang K; Anderson A; Leyendecker JR
AJR Am J Roentgenol; 2014 Oct; 203(4):W421-8. PubMed ID: 25247971
[TBL] [Abstract][Full Text] [Related]
4. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
[TBL] [Abstract][Full Text] [Related]
5. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
[TBL] [Abstract][Full Text] [Related]
7. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
[TBL] [Abstract][Full Text] [Related]
8. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
[TBL] [Abstract][Full Text] [Related]
9. Prediction of nuclear grade of clear cell renal cell carcinoma with MRI: intratumoral susceptibility signal intensity versus necrosis.
Chen J; Sun J; Xing W; Ding J; Chen T; Dai Y; Sun J; Hu J
Acta Radiol; 2014 Apr; 55(3):378-84. PubMed ID: 23946232
[TBL] [Abstract][Full Text] [Related]
10. MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes.
Doshi AM; Huang WC; Donin NM; Chandarana H
AJR Am J Roentgenol; 2015 Apr; 204(4):798-803. PubMed ID: 25794069
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
12. Textural differences in apparent diffusion coefficient between low- and high-stage clear cell renal cell carcinoma.
Kierans AS; Rusinek H; Lee A; Shaikh MB; Triolo M; Huang WC; Chandarana H
AJR Am J Roentgenol; 2014 Dec; 203(6):W637-44. PubMed ID: 25415729
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma in patients with acquired cystic disease of the kidney: assessment using a combination of T2-weighted, diffusion-weighted, and chemical-shift MRI without the use of contrast material.
Akita H; Jinzaki M; Akita A; Mikami S; Oya M; Kuribayashi S
J Magn Reson Imaging; 2014 Apr; 39(4):924-30. PubMed ID: 24123320
[TBL] [Abstract][Full Text] [Related]
15. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
16. Prediction of growth rate of solid renal masses: utility of MR imaging features--preliminary experience.
Dodelzon K; Mussi TC; Babb JS; Taneja SS; Rosenkrantz AB
Radiology; 2012 Mar; 262(3):884-93. PubMed ID: 22267588
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI of solid renal masses: pearls and pitfalls.
Ramamurthy NK; Moosavi B; McInnes MD; Flood TA; Schieda N
Clin Radiol; 2015 Mar; 70(3):304-16. PubMed ID: 25472466
[TBL] [Abstract][Full Text] [Related]
18. Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging.
Verma SK; Mitchell DG; Yang R; Roth CG; O'Kane P; Verma M; Parker L
Radiology; 2010 May; 255(2):501-7. PubMed ID: 20160001
[TBL] [Abstract][Full Text] [Related]
19. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM
AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
